(Q42745781)
Statements
1 reference
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies (English)
1 reference
Julian R Molina
1 reference
Glen J Weiss
1 reference
Jeffrey R Infante
1 reference
E Gabriela Chiorean
1 reference
Mitesh J Borad
1 reference
Johanna C Bendell
1 reference
Raoul Tibes
1 reference
Ramesh K Ramanathan
1 reference
Karen Lewandowski
1 reference
Suzanne F Jones
1 reference
Mario E Lacouture
1 reference
Virginia K Langmuir
1 reference
Hank Lee
1 reference
Stew Kroll
1 reference
Howard A Burris
1 reference
17 March 2011
1 reference
1 reference
Identifiers
1 reference